![David Gobel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Gobel
Director/Board Member at
VIVOSIM LABS, INC.
Net worth: 4 365 $ as of 2026-08-30
Profile
Mr. David Gobel is an Independent Director at VivoSim Labs, Inc., a Chairman at Turn Biotechnologies, Inc., a Chief Executive Officer at Methuselah Capital Management LLC, a Chief Executive Officer at Methuselah Funds LLC, an Independent Director at Oisin Biotechnologies, Inc. and a Chief Executive Officer at Methuselah Foundation.
He is on the Board of Directors at VivoSim Labs, Inc., Leucadia Therapeutics, Inc. and Oisin Biotechnologies, Inc. Mr. Gobel was previously employed as a Chief Venture Strategist by Transportation Security Administration.
He also served on the board at Volumetric Biotechnologies, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VIVOSIM LABS INC 0.58% | 2026-08-12 | 15,000 ( 0.58% ) | 4 365 $ | 2026-08-30 |
David Gobel active positions
| Companies | Position | Start |
|---|---|---|
| VIVOSIM LABS, INC. | Director/Board Member | 2020-09-14 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Director/Board Member | 2014-11-30 |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Chief Executive Officer | 2016-12-31 |
Leucadia Therapeutics, Inc.
 Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Director/Board Member | 2015-09-30 |
Methuselah Foundation
 Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Chief Executive Officer | 2001-08-31 |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Chairman | 2020-04-30 |
Methuselah Funds LLC
 Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Chief Executive Officer | 2016-11-30 |
Former positions of David Gobel
| Companies | Position | End |
|---|---|---|
Volumetric Biotechnologies, Inc. | Director/Board Member | 2019-12-31 |
Transportation Security Administration
 Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Corporate Officer/Principal | 2013-02-28 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Transportation Security Administration
Transportation Security Administration General GovernmentGovernment Operates and manages transportation security system | Government |
Methuselah Foundation
Methuselah Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a biomedical charity which focuses on human lifespan and improving longevity | Miscellaneous |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Provides biological solutions to degenerative aging conditions | Health Technology |
Methuselah Funds LLC
Methuselah Funds LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management invests in companies located in the United States. The firm target companies operating across a broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops diagnostic algorithm for alzheimer disease prevention and treatment | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Volumetric Biotechnologies, Inc. |
- Stock Market
- Insiders
- David Gobel
